Download PDF
Thromb Haemost 1994; 72(02): 318-321
DOI: 10.1055/s-0038-1648860
Original Article
Schattauer GmbH Stuttgart

Desulfated Hirugen (Hirudin 54-65) Induces Endothelium-Dependent Relaxation of Porcine Pulmonary Arteries

Erika Glusa
The University of Jena, Medical School, Center for Vascular Biology and Medicine, Erfurt, Germany
› Author Affiliations
Further Information

Publication History

Received 03 February 1994

Accepted after revision 13 April 1994

Publication Date:
24 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Desulfated hirugen (hirudin 54-65) at concentrations from 0.1 to 2 μM was found to relax PGF2α-precontracted ring segments of porcine pulmonary arteries with intact endothelium. The relaxation was associated with a pronounced increase in cGMP in the vessels. This endothelium-dependent relaxant effect depended on the extracellular calcium ion concentration and was probably due to the release of endothelium-derived NO as indicated by its susceptibility to blockade of the NO synthesis by NG-nitro-L-arginine. In the presence of indomethacin (3 μM) the maximum hirugen effect was significantly diminished by about 25%. In contrast, neither the sulfated hirugen nor recombinant desulfato hirudin at equimolar concentrations exerted endothelium-dependent relaxation. Hence, the relaxant effect did not correspond to the anticoagulant activity. Desulfated hirugen can be assigned to the group of well-known peptides causing vasodilatation via an endothelium-dependent mechanism.

 

  • References

  • 1 Coughlin SR, Vu T-KH, Hung DT, Wheaton VI. Expression cloning and characterization of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Semin Thromb Hemost 1992; 18: 161-166
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Glusa E. Vascular effects of thrombin. Semin Thromb Hemost 1992; 18: 296-304
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Marwardt F. Hirudin: The promising antithrombotic. Cardiovasc Drug Res 1992; 10: 211-232
    PubMedGoogle Scholar
  • 4 Maraganore JM. Thrombin, thrombin inhibitors, and the arterial thrombotic process. Thromb Haemost 1993; 70: 208-211
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Ofosu FA, FentonII JW, Maraganore I, Blajchman MA, Yang X, Smith L, Anvari N, Buchanan MR, Hirsh J. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of a-thrombin. Biochem J 1992; 283: 893-897
    CrossrefPubMedGoogle Scholar
  • 6 Maraganore JM, Chao B, Joseph ML, Jablonski J, Ramachandran KL. Anticoagulant activity of synthetic hirudin peptides. J Biol Chem 1989; 264: 8692-8698
    PubMedGoogle Scholar
  • 7 Kelly AB, Maraganore JM, Bourdon P, Hanson SR, Harker LA. Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin. Proc Natl Acad Sci USA 1992; 89: 6040-6044
    CrossrefPubMedGoogle Scholar
  • 8 Naski MC, Fenton JW, Maraganore JM, Olson ST, Shafer JA. The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen. J Biol Chem 1990; 265: 13484-13489
    PubMedGoogle Scholar
  • 9 Rowand JK, Marucha P, Berliner LJ. Hirudin C-terminal fragments inhibit thrombin-induced neutrophil chemotaxis. Thromb Haemost 1992; 67: 289-291
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Jakubowski JA, Maraganore JM. Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin. Blood 1990; 75: 399-406
    PubMedGoogle Scholar
  • 1 Jandrot-Perrus M, Hpisse MG, Krstenansky JL, Bezeaud A, Guillin MC. Effect of the hirudin carboxy-terminal peptide 54-6.5 on the interaction of thrombin with platelets. Thromb Haemost 1991; 66: 300-305
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Hoch FJ, Wirth K, Albus U, Linz W, Gerhards HJ, Wiemer G, Henke ST, Breipohl G, Konig W, Knolle J, Scholkens BA. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol 1991; 102: 769-773
    CrossrefPubMedGoogle Scholar
  • 13 van de Voorde J, Leusen I. Role of the endothelium in the vasodilator 1 response of rat thoracic aorta to histamine. Eur J Pharmacol 1983; 87: 113-120
    CrossrefPubMedGoogle Scholar
  • 14 Martin W, Cusack NJ, Carleton JS, Gordon JL. Specifity of P2-purinocep2 tor that mediates endothelium-dependent relaxation of the pig aorta. Eur J Pharmacol 1985; 108: 295-299
    CrossrefPubMedGoogle Scholar
  • 15 Molderings GJ, Engel G, Roth E, Göthert M. Spiperone-induced endothe-2 lium-dependent relaxation of porcine coronary artery: An investigation into the underlying mechanism. Arch Int Pharmacodyn Ther 1992; 319: 24-37
    PubMedGoogle Scholar
  • 16 Bolton TB, Clapp LH. Endothelial-dependent relaxant actions of carbachol and substance P in arterial smooth muscle. Br J Pharmacol 1986; 87: 713-723
    CrossrefPubMedGoogle Scholar
  • 17 Namiki A, HirataE Y, Ishikawa M, Moroi M, Aikawa J, Machii K. Endothe-lin-1 and endothelin-3-induced vasorelaxation via common generation of endothelium-derived nitric oxide. Life Sci 1992; 50: 677-682
    CrossrefPubMedGoogle Scholar
  • 18 Pearson PJ, Evora PRB, Ayrancioglu K, Schaff HV. Protamine releases endothelium-derived relaxing factor from systemic arteries. Circulation 1992; 86: 298-294
    PubMedGoogle Scholar
  • 19 Akata T, Kodama K, Takahashi S. Effects of heparin on the vasodilator action of protamine in rabbit mesenteric artery. Br J Pharmacol 1993; 109: 1247-1253
    CrossrefPubMedGoogle Scholar
  • 20 Davis JM, Williams KI. Endothelial-dependent relaxant effects of vasoactive intestinal peptides and arachidonic acid in rat aortic strips. Prostaglandins 1984; 27: 195-201
    CrossrefPubMedGoogle Scholar
  • 21 Katusic ZS, Shepherd JT, Vanhoutte PM. Vasopressin causes endothelium-dependent relaxation of the canine basilar artery. Circ Res 1984; 55: 575-579
    CrossrefPubMedGoogle Scholar
  • 22 Thomas G, Mostaghim R, Ramwell PW. Endothelium dependent vascular relaxation by arginine containing polypeptides. Biochem Biophys Res Commun 1986; 141: 446-451
    CrossrefPubMedGoogle Scholar
  • 23 Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature 1985; 313: 54-56
    CrossrefPubMedGoogle Scholar